Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CTMX |
---|---|---|
09:32 ET | 48570 | 1.98 |
09:34 ET | 101542 | 1.99 |
09:36 ET | 22402 | 1.9592 |
09:38 ET | 75509 | 1.9907 |
09:39 ET | 13741 | 2 |
09:41 ET | 92287 | 1.9821 |
09:43 ET | 16404 | 1.9813 |
09:45 ET | 13640 | 1.98 |
09:48 ET | 114865 | 1.9907 |
09:50 ET | 89134 | 1.99 |
09:52 ET | 105899 | 2 |
09:54 ET | 101666 | 1.99 |
09:56 ET | 2149 | 1.9912 |
09:57 ET | 20590 | 1.995 |
09:59 ET | 6013 | 1.995 |
10:01 ET | 3826 | 1.995 |
10:03 ET | 12684 | 1.995 |
10:06 ET | 2552 | 1.9993 |
10:08 ET | 72304 | 1.975 |
10:10 ET | 14140 | 1.985 |
10:12 ET | 12650 | 1.985 |
10:14 ET | 2934 | 1.98 |
10:15 ET | 81699 | 1.995 |
10:17 ET | 74165 | 2 |
10:19 ET | 13158 | 2.001 |
10:21 ET | 5556 | 2 |
10:24 ET | 22329 | 2 |
10:26 ET | 29504 | 2 |
10:28 ET | 68006 | 1.985 |
10:30 ET | 14208 | 1.99 |
10:32 ET | 2007 | 1.9801 |
10:33 ET | 1716 | 1.99 |
10:35 ET | 55562 | 1.995 |
10:37 ET | 76291 | 2 |
10:39 ET | 41843 | 2 |
10:42 ET | 34896 | 2 |
10:44 ET | 83471 | 1.985 |
10:46 ET | 6600 | 1.985 |
10:48 ET | 100 | 1.985 |
10:50 ET | 4000 | 1.99 |
10:51 ET | 820 | 1.99 |
10:53 ET | 1384 | 1.99 |
10:55 ET | 1000 | 1.985 |
10:57 ET | 2720 | 1.99 |
11:00 ET | 2513 | 1.99 |
11:02 ET | 42708 | 2 |
11:04 ET | 12418 | 1.995 |
11:06 ET | 5050 | 1.9976 |
11:08 ET | 6180 | 1.995 |
11:09 ET | 6300 | 1.995 |
11:11 ET | 2459 | 2 |
11:13 ET | 52099 | 2 |
11:15 ET | 26324 | 1.995 |
11:18 ET | 2053 | 1.995 |
11:20 ET | 52781 | 2 |
11:22 ET | 14721 | 2 |
11:24 ET | 49056 | 1.99 |
11:26 ET | 18400 | 2 |
11:27 ET | 12779 | 1.99 |
11:29 ET | 8541 | 1.995 |
11:31 ET | 59962 | 1.995 |
11:33 ET | 61520 | 1.9714 |
11:36 ET | 38297 | 1.988 |
11:38 ET | 5145 | 1.99 |
11:40 ET | 10572 | 1.985 |
11:42 ET | 16320 | 1.99 |
11:44 ET | 500 | 1.98 |
11:45 ET | 1896 | 1.98 |
11:47 ET | 600 | 1.98 |
11:49 ET | 1500 | 1.98 |
11:51 ET | 2098 | 1.99 |
11:54 ET | 4320 | 1.99 |
11:56 ET | 5364 | 1.988 |
11:58 ET | 18466 | 2 |
12:00 ET | 32922 | 1.995 |
12:02 ET | 800 | 1.995 |
12:03 ET | 1521 | 1.995 |
12:05 ET | 700 | 1.995 |
12:07 ET | 2680 | 1.995 |
12:09 ET | 600 | 1.995 |
12:12 ET | 2635 | 2 |
12:14 ET | 1555 | 2 |
12:16 ET | 2529 | 2 |
12:18 ET | 3158 | 2 |
12:20 ET | 1877 | 2 |
12:21 ET | 9517 | 2 |
12:23 ET | 27138 | 1.995 |
12:25 ET | 1300 | 1.995 |
12:27 ET | 1418 | 1.995 |
12:30 ET | 400 | 1.995 |
12:32 ET | 3552 | 1.995 |
12:34 ET | 400 | 1.995 |
12:36 ET | 12844 | 1.995 |
12:38 ET | 1300 | 1.995 |
12:39 ET | 900 | 1.995 |
12:41 ET | 800 | 1.99 |
12:43 ET | 41725 | 2 |
12:45 ET | 5340 | 2 |
12:48 ET | 900 | 2 |
12:50 ET | 3678 | 2 |
12:52 ET | 6731 | 1.9934 |
12:54 ET | 13374 | 1.9986 |
12:56 ET | 8164 | 1.995 |
12:57 ET | 300 | 1.99 |
12:59 ET | 1214 | 2 |
01:01 ET | 817 | 2 |
01:03 ET | 1300 | 1.995 |
01:06 ET | 1100 | 1.995 |
01:08 ET | 13700 | 2 |
01:10 ET | 800 | 2 |
01:12 ET | 13157 | 1.993 |
01:14 ET | 900 | 1.995 |
01:15 ET | 4697 | 1.995 |
01:17 ET | 1400 | 1.995 |
01:19 ET | 700 | 1.995 |
01:21 ET | 1811 | 1.995 |
01:24 ET | 18497 | 1.9802 |
01:26 ET | 40421 | 1.985 |
01:28 ET | 780 | 1.9892 |
01:30 ET | 4006 | 1.985 |
01:32 ET | 450 | 1.985 |
01:33 ET | 5630 | 1.99 |
01:35 ET | 658 | 1.988 |
01:37 ET | 10700 | 1.985 |
01:39 ET | 2601 | 1.98 |
01:42 ET | 1850 | 1.985 |
01:44 ET | 11571 | 1.975 |
01:46 ET | 100 | 1.98 |
01:48 ET | 2913 | 1.9775 |
01:50 ET | 500 | 1.975 |
01:51 ET | 2400 | 1.98 |
01:53 ET | 3895 | 1.98 |
01:55 ET | 416 | 1.98 |
01:57 ET | 516 | 1.9781 |
02:00 ET | 2516 | 1.975 |
02:02 ET | 13090 | 1.98 |
02:04 ET | 14839 | 1.98 |
02:06 ET | 5000 | 1.9785 |
02:08 ET | 8317 | 1.965 |
02:09 ET | 7255 | 1.975 |
02:11 ET | 200 | 1.98 |
02:13 ET | 6029 | 1.98 |
02:15 ET | 2900 | 1.975 |
02:18 ET | 18337 | 1.96 |
02:20 ET | 2900 | 1.96 |
02:22 ET | 3021 | 1.955 |
02:24 ET | 16045 | 1.96 |
02:26 ET | 3739 | 1.96 |
02:27 ET | 4340 | 1.9516 |
02:29 ET | 531 | 1.96 |
02:31 ET | 28490 | 1.935 |
02:33 ET | 20828 | 1.945 |
02:36 ET | 17072 | 1.95 |
02:38 ET | 2320 | 1.94 |
02:40 ET | 3512 | 1.95 |
02:42 ET | 18249 | 1.955 |
02:44 ET | 5045 | 1.955 |
02:45 ET | 1600 | 1.96 |
02:47 ET | 5189 | 1.95 |
02:49 ET | 3863 | 1.95 |
02:51 ET | 12098 | 1.96 |
02:54 ET | 4450 | 1.96 |
02:56 ET | 1106 | 1.955 |
02:58 ET | 700 | 1.96 |
03:00 ET | 72892 | 1.97 |
03:02 ET | 22664 | 1.965 |
03:03 ET | 3602 | 1.97 |
03:05 ET | 3351 | 1.97 |
03:07 ET | 900 | 1.97 |
03:09 ET | 2270 | 1.97 |
03:12 ET | 4900 | 1.965 |
03:14 ET | 1401 | 1.965 |
03:16 ET | 2372 | 1.965 |
03:18 ET | 14258 | 1.97 |
03:20 ET | 30194 | 1.965 |
03:21 ET | 1791 | 1.97 |
03:23 ET | 967 | 1.97 |
03:25 ET | 17302 | 1.96 |
03:27 ET | 19178 | 1.965 |
03:30 ET | 12732 | 1.965 |
03:32 ET | 13214 | 1.97 |
03:34 ET | 6027 | 1.965 |
03:36 ET | 29808 | 1.97 |
03:38 ET | 4600 | 1.965 |
03:39 ET | 9799 | 1.965 |
03:41 ET | 73888 | 1.96 |
03:43 ET | 57748 | 1.945 |
03:45 ET | 6885 | 1.945 |
03:48 ET | 25276 | 1.95 |
03:50 ET | 37539 | 1.95 |
03:52 ET | 2100 | 1.945 |
03:54 ET | 17700 | 1.945 |
03:56 ET | 28147 | 1.955 |
03:57 ET | 101224 | 1.95 |
03:59 ET | 127177 | 1.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CytomX Therapeutics Inc | 151.2M | 9.9x | --- |
Spero Therapeutics Inc | 86.2M | 4.0x | --- |
2Seventy Bio Inc | 243.1M | -1.1x | --- |
Rigel Pharmaceuticals Inc | 166.2M | -8.5x | --- |
Alimera Sciences Inc | 171.8M | -1.5x | --- |
Seres Therapeutics Inc | 135.3M | -1.6x | --- |
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $151.2M |
---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.17 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 9.9x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | 8.1x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.